| Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts J Sponheim, J Pollheimer, T Olsen, J Balogh, C Hammarström, T Loos, ... The American journal of pathology 177 (6), 2804-2815, 2010 | 211 | 2010 |
| Nucleophosmin/anaplastic lymphoma kinase (NPM/ALK) oncoprotein induces the T regulatory cell phenotype by activating STAT3 M Kasprzycka, M Marzec, X Liu, Q Zhang, MA Wasik Proceedings of the National Academy of Sciences 103 (26), 9964-9969, 2006 | 173 | 2006 |
| Mantle cell lymphoma cells express predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase activity M Marzec, M Kasprzycka, R Lai, AB Gladden, P Wlodarski, E Tomczak, ... Blood 108 (5), 1744-1750, 2006 | 170 | 2006 |
| Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway M Marzec, M Kasprzycka, X Liu, M El-Salem, K Halasa, PN Raghunath, ... Oncogene 26 (38), 5606-5614, 2007 | 130 | 2007 |
| Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf M Marzec, M Kasprzycka, X Liu, PN Raghunath, P Wlodarski, MA Wasik Oncogene 26 (6), 813-821, 2007 | 107 | 2007 |
| Inhibition of ALK enzymatic activity in T-cell lymphoma cells induces apoptosis and suppresses proliferation and STAT3 phosphorylation independently of Jak3 M Marzec, M Kasprzycka, A Ptasznik, P Wlodarski, Q Zhang, N Odum, ... Laboratory investigation 85 (12), 1544-1554, 2005 | 105 | 2005 |
| Differential effects of interleukin-2 and interleukin-15 versus interleukin-21 on CD4+ cutaneous T-cell lymphoma cells M Marzec, K Halasa, M Kasprzycka, M Wysocka, X Liu, JW Tobias, ... Cancer research 68 (4), 1083-1091, 2008 | 98 | 2008 |
| The alarmin IL-33 is a notch target in quiescent endothelial cells E Sundlisæter, RJ Edelmann, J Hol, J Sponheim, AM Küchler, M Weiss, ... The American journal of pathology 181 (3), 1099-1111, 2012 | 89 | 2012 |
| Activation of mammalian target of rapamycin in transformed B lymphocytes is nutrient dependent but independent of Akt, mitogen-activated protein kinase/extracellular signal … P Wlodarski, M Kasprzycka, X Liu, M Marzec, ES Robertson, A Slupianek, ... Cancer research 65 (17), 7800-7808, 2005 | 88 | 2005 |
| IL-2– and IL-15–induced activation of the rapamycin-sensitive mTORC1 pathway in malignant CD4+ T lymphocytes M Marzec, X Liu, M Kasprzycka, A Witkiewicz, PN Raghunath, M El-Salem, ... Blood, The Journal of the American Society of Hematology 111 (4), 2181-2189, 2008 | 81 | 2008 |
| γc-signaling cytokines induce a regulatory T cell phenotype in malignant CD4+ T lymphocytes M Kasprzycka, Q Zhang, A Witkiewicz, M Marzec, M Potoczek, X Liu, ... The Journal of Immunology 181 (4), 2506-2512, 2008 | 66 | 2008 |
| Interleukin-33 drives a proinflammatory endothelial activation that selectively targets nonquiescent cells J Pollheimer, J Bodin, O Sundnes, RJ Edelmann, SS Skånland, ... Arteriosclerosis, thrombosis, and vascular biology 33 (2), e47-e55, 2013 | 60 | 2013 |
| Tenascins in fibrotic disorders—from bench to bedside M Kasprzycka, C Hammarström, G Haraldsen Cell Adhesion & Migration 9 (1-2), 83-89, 2015 | 55 | 2015 |
| Apoptosis of T cells in the first trimester human decidua M JERZAK, M Kasprzycka, P WIERBICKI, J Kotarski, A GÓRSKI American Journal of Reproductive Immunology 40 (3), 130-135, 1998 | 54 | 1998 |
| Expression and oncogenic role of Brk (PTK6/Sik) protein tyrosine kinase in lymphocytes M Kasprzycka, M Majewski, ZJ Wang, A Ptasznik, M Wysocka, Q Zhang, ... The American journal of pathology 168 (5), 1631-1641, 2006 | 52 | 2006 |
| Anaplastic lymphoma kinase (ALK)-induced malignancies: novel mechanisms of cell transformation and potential therapeutic approaches MA Wasik, Q Zhang, M Marzec, M Kasprzycka, HY Wang, X Liu Seminars in oncology 36, S27-S35, 2009 | 43 | 2009 |
| Inhibition of endothelial NOTCH1 signaling attenuates inflammation by reducing cytokine-mediated histone acetylation at inflammatory enhancers LC Poulsen, RJ Edelmann, S Krüger, R Diéguez-Hurtado, A Shah, ... Arteriosclerosis, thrombosis, and vascular biology 38 (4), 854-869, 2018 | 41 | 2018 |
| Cyclolinopeptide: a novel immunosuppressive agent with potential anti-lipemic activity A Górski, M Kasprzycka, M Nowaczyk, Z Wieczoreck, IZ Siemion, ... Transplantation proceedings 1 (33), 553, 2001 | 38 | 2001 |
| PU. 1 activates transcription of SHP-1 gene in hematopoietic cells P Wlodarski, Q Zhang, X Liu, M Kasprzycka, M Marzec, MA Wasik Journal of biological chemistry 282 (9), 6316-6323, 2007 | 37 | 2007 |
| Statins affect the presentation of endothelial chemokines by targeting to multivesicular bodies J Hol, K Otterdal, UM Breland, E Stang, TM Pedersen, K Hagelsteen, ... PLoS One 7 (7), e40673, 2012 | 29 | 2012 |
Michal MarzecUniversity of CopenhagenVerified email at sund.ku.dk
